首页 › 基金 › Frazier Life Sciences Management, L.P. › MIRM
Frazier Life Sciences Management, L.P. 对 MIRM 的持仓历史
MIRUM PHARMACEUTICALS INC · 医疗保健
Frazier Life Sciences Management, L.P. 在 Q2 2026 的 13F 申报中披露持有 MIRM(MIRUM PHARMACEUTICALS INC)7,679,684 股,市值约 US$899.1M,约占其申报组合的 19.58%,在其申报持仓中市值排名第 1 位。 Frazier Life Sciences Management, L.P. 最近 12 个申报季度中有 12 个季度披露了 MIRM 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Frazier Life Sciences Management, L.P. 对 MIRM 的持仓演变
Frazier Life Sciences Management, L.P. 于 Q3 2023 首次披露 MIRM 持仓:6,470,392 股(约 US$204.5M)。 该持仓在 Q2 2026 达到峰值 7,679,684 股,市值约 US$899.1M。 在 12 次申报中,Frazier Life Sciences Management, L.P. 3 次增持、0 次减持、8 次保持不变。 最近一期申报(Q2 2026)显示持股 7,679,684 股、市值约 US$899.1M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 6.47M | $204.46M | 新进 |
| Q4 2023 | 6.50M | $191.74M | 持有 |
| Q1 2024 | 6.50M | $163.16M | 持有 |
| Q2 2024 | 6.50M | $222.08M | 持有 |
| Q3 2024 | 6.57M | $256.25M | 增持 |
| Q4 2024 | 6.57M | $271.69M | 持有 |
| Q1 2025 | 6.80M | $306.12M | 增持 |
| Q2 2025 | 6.80M | $345.80M | 持有 |
| Q3 2025 | 6.80M | $498.15M | 持有 |
| Q4 2025 | 6.80M | $536.75M | 持有 |
| Q1 2026 | 7.68M | $709.45M | 增持 |
| Q2 2026 | 7.68M | $899.06M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 MIRM 与 13F 数据
MIRM(MIRUM PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 61 只申报持有 MIRM,申报仓位最大的包括:EVENTIDE ASSET MANAGEMENT, LLC (US$146.2M), TANG CAPITAL MANAGEMENT LLC (US$144.7M), Novo Holdings A/S (US$131.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 MIRM 的基金
- EVENTIDE ASSET MANAGEMENT, LLC 1.25M 股 · $146.20M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.24M 股 · $144.70M · Q2 2026
- Novo Holdings A/S 1.12M 股 · $131.70M · Q2 2026
- TCG Crossover Management, LLC 1.06M 股 · $124.33M · Q2 2026
- BVF INC/IL 1.06M 股 · $123.63M · Q2 2026
- Rock Springs Capital Management LP 798.14K 股 · $93.44M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 24.65M 股 · $91.66M · Q2 2026
- CAPSTONE INVESTMENT ADVISORS, LLC 18.45M 股 · $68.30M · Q2 2026
- EMERALD ADVISERS, LLC 468.30K 股 · $54.82M · Q2 2026
- BAKER BROS. ADVISORS LP 445.98K 股 · $52.21M · Q2 2026
- NEXT CENTURY GROWTH INVESTORS LLC 420.21K 股 · $49.19M · Q2 2026
- BOONE CAPITAL MANAGEMENT LLC 415.64K 股 · $48.66M · Q2 2026
更多关于 Frazier Life Sciences Management, L.P.
常见问题
How long has Frazier Life Sciences Management, L.P. held MIRM?
Frazier Life Sciences Management, L.P. has disclosed MIRM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Frazier Life Sciences Management, L.P.'s current position in MIRM?
As of Q2 2026, Frazier Life Sciences Management, L.P. holds 7.68M shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $899.06M, representing 19.58% of its reported portfolio and ranking #1.
Has Frazier Life Sciences Management, L.P. been buying or selling MIRM?
In the latest 13F filing (Q2 2026), Frazier Life Sciences Management, L.P. held unchanged its position in MIRM. The position peaked in Q2 2026 at 7.68M shares.
Which other funds hold MIRM?
Other major institutional holders of MIRM include EVENTIDE ASSET MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, Novo Holdings A/S, among 61 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.